CJC-1295 with DAC
Long-acting GHRH analog with Drug Affinity Complex modification for sustained-exposure studies.
For laboratory research and API development only. Each lot includes a COA and HPLC chromatogram; LC-MS is available on request.
CJC-1295 NO DAC
GHRH analog without DAC modification. Shorter half-life for pulsatile dosing studies.
CJC-1295 no DAC 5mg + IPA 5mg
GHRH analog plus GH secretagogue combination spec.
AOD9604
HGH C terminal-fragment analog focused on fat metabolism without the full GH pathway.
IGF-1LR3
Long-acting insulin-like growth factor analog for cell-proliferation and muscle-growth models.
